Shares outstanding · 2020–2025
Xeris Biopharma shares outstanding
166M+11.2% · FY2025
Xeris Biopharma (XERS) reported 166M in shares outstanding for fiscal 2025, +11.2% year on year.
Shares outstanding — Shares outstanding is the number of shares in issue at the reporting date. A falling count usually means the company is buying back stock; a rising one means it is issuing.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2020–2025 compound annual growth +22.8%
Shares outstanding at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Xeris Biopharma shares outstanding |url=https://companiesranked.com/en/company/xeris-biopharma/shares-outstanding |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Xeris Biopharma shares outstanding. CompaniesRanked. https://companiesranked.com/en/company/xeris-biopharma/shares-outstandingBibTeX
@misc{companiesranked-en-company-xeris-biopharma-shares-outstanding-2026,
author = {{CompaniesRanked}},
title = {{Xeris Biopharma shares outstanding}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/xeris-biopharma/shares-outstanding}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0001867096-26-000065 · August 6, 2026
{{cite web |title=Xeris Biopharma shares outstanding — 10-Q (0001867096-26-000065) |url=https://www.sec.gov/Archives/edgar/data/1867096/000186709626000065/xers-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-06}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.